ClinicalTrials.Veeva

Menu

rTMS in Aphasic Patients With Neuroimage Assessments

T

Taipei Veterans General Hospital

Status

Unknown

Conditions

Stroke
Aphasia

Treatments

Device: Sham stimulation
Device: repetitive transcranial magnetic stimulation (rTMS)

Study type

Interventional

Funder types

Other

Identifiers

NCT03059225
2014-05-003A

Details and patient eligibility

About

The refinement of repetitive transcranial magnetic stimulation (rTMS) has highlighted its merit in terms of learning programs as a treatment for aftereffect augmentation. Nevertheless, the efficacy of synchronous rTMS protocol integrated with computer-integrated speech training is not well understood. It is also not clear regarding the efficacy of compound bi-hemispheric stimulation protocol. The aim of the study is to investigate language response to these new strategies and to determine the longevity of the therapeutic outcome. Advanced MR neuroimaging techniques, such as fMRI and DTI, are powerful tools to evaluate the concomitant nervous changes after rTMS treatment on aphasic patients. The knowledge from fMRI and DTI microstructural evolution provides insight into underlined mechanism operating the language improvement.

Full description

The efficacy of synchronous rTMS protocol integrated with computer-integrated speech training is not well understood. It is also not clear regarding the efficacy of inhibitory or excitatory stimulation protocol. The aim of the study is to investigate language response to these new strategies and to determine the longevity of the therapeutic outcome. Advanced MR neuroimaging techniques, such as fMRI and DTI, are powerful tools to evaluate the concomitant nervous changes after rTMS treatment on aphasic patients. The knowledge from fMRI and DTI microstructural evolution provides insight into underlined mechanism operating the language improvement

Enrollment

120 estimated patients

Sex

All

Ages

30 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aphasic stroke in chronic stage (over 3 months)

Exclusion criteria

  • No seizure history, no brain surgery history, no electronic device in brain or chest, no dementia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

120 participants in 3 patient groups

Experimental
Experimental group
Description:
repetitive transcranial magnetic stimulation (rTMS) intervention of contralesional 1Hz-rTMS for 10 daily sessions.
Treatment:
Device: repetitive transcranial magnetic stimulation (rTMS)
Sham stimulation
Sham Comparator group
Description:
Sham treatment for 2-week inhibitory non-dominate hemisphere rTMS program.
Treatment:
Device: Sham stimulation
High frequency rTMS
Experimental group
Description:
High-frequency rTMS to ipsilesional region for 10 daily sessions.
Treatment:
Device: repetitive transcranial magnetic stimulation (rTMS)

Trial contacts and locations

1

Loading...

Central trial contact

Po-Yi Tsai, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems